Back to search

Article

Predicting temozolomide response in low-grade glioma patients with large-scale machine learning

2024-12-23

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Temozolomide is the primary chemotherapeutic agent and first-line treatment for low-grade glioma (LGG). Although LGGs are generally less aggressive than high-grade gliomas (HGGs), they can eventually progress into HGGs, making it crucial to maximise the efficacy of initial LGG treatment. <h4>Methods</h4> In this study, we analysed data from 109 LGG patients in The Cancer Ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2b8eeca8-d019-50e0-a240-7bfe2680dfe1
DOI
10.1101/2024.12.22.629995
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting temozolomide response in low-grade glioma patients with large-scale machine learningDOI 10.1101/2024.12.22.629995
Identification of a three-long non-coding RNA signature for predicting survival of temozolomide-treated isocitrate dehydrogenase mutant low-grade gliomas.Semantic proximity
A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.Semantic proximity
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival.Semantic proximity
Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelinesSemantic proximity
A gene signature predicting prognosis of patients with low- grade gliomas receiving temozolomide therapySemantic proximity
Multi-omics biomarker selection and outlier detection across WHO glioma classifications via robust sparse multinomial regressionSemantic proximity
Integrative Multi-Omics Profiling and Machine Learning Identify Key Molecular Determinants Distinguishing Glioblastoma from Lower-Grade GliomaSemantic proximity
Computational genomics of brain tumors: identification and characterization of glioma candidate biomarkers through multi-omics integrative molecular profilingSemantic proximity
LUNAR: A Deep Learning Model to Predict Glioma Recurrence Using Integrated Genomic and Clinical DataSemantic proximity
Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approachSemantic proximity
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaSemantic proximity
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric studySemantic proximity
Select a neighboring publication to make it the new centre.